List of texts adopted at the November 2017 session of the European Pharmacopoeia Commission
|
|
|
- Magnus Cook
- 6 years ago
- Views:
Transcription
1 Pharmeuropa Useful information February List of texts adopted at the November 2017 session of the European Pharmacopoeia Commission NEW TEXTS MONOGRAPHS Herbal drugs and herbal drug preparations Gastrodia rhizome (2721) Lightyellow sophora root (2440) Homoeopathic preparations Digitalis purpurea for homoeopathic preparations (2705) Monographs Haemofiltration and haemodiafiltration, concentrated solutions for (2770) Imidacloprid for veterinary use (2924) Infliximab concentrated solution (2928) Phenoxymethylpenicillin (benzathine) tetrahydrate (2636) Phytomenadione, racemic (3011) Podophyllotoxin (2750) Rotigotine (3014) Sulfobutylbetadex sodium (2804) Zoledronic acid monohydrate (2743) REVISED TEXTS GENERAL CHAPTERS Capillary viscometer method Drop point Gas chromatography Liquid chromatography Size-exclusion chromatography Conductivity Identification of fatty oils by thin-layer chromatography Pesticide residues
2 2 Pharmeuropa Useful information February Materials based on plasticised poly(vinyl chloride) for containers for human blood and blood components Materials based on plasticised poly(vinyl chloride) for tubing used in sets for the transfusion of blood and blood components Plastic additives Materials based on plasticised poly(vinyl chloride) for containers for aqueous solutions for intravenous infusion Glass containers for pharmaceutical use Sterile plastic containers for human blood and blood components Empty sterile containers of plasticised poly(vinyl chloride) for human blood and blood components Sterile containers of plasticised poly(vinyl chloride) for human blood containing anticoagulant solution 5.8. Pharmacopoeial harmonisation Names of herbal drugs used in traditional Chinese medicine MONOGRAPHS General monographs Allergen products (1063) Immunosera for human use, animal (0084) Dosage forms Granules (0499) Pressurised pharmaceutical preparations (0523) Sticks (1154) Vaccines for human use Anthrax vaccine for human use (adsorbed, prepared from culture filtrates) (2188) Diphtheria, tetanus, pertussis (acellular, component) and haemophilus type b conjugate vaccine (adsorbed) (1932) Haemophilus type b conjugate vaccine (1219) Hepatitis A (inactivated, adsorbed) and typhoid polysaccharide vaccine (2597) Hepatitis A (inactivated) and hepatitis B (rdna) vaccine (adsorbed) (1526) Hepatitis A vaccine (inactivated, adsorbed) (1107) Hepatitis A vaccine (inactivated, virosome) (1935) Hepatitis B vaccine (rdna) (1056) Human papillomavirus vaccine (rdna) (2441)
3 Pharmeuropa Useful information February Influenza vaccine (split virion, inactivated) (0158) Influenza vaccine (surface antigen, inactivated) (0869) Influenza vaccine (surface antigen, inactivated, prepared in cell cultures) (2149) Influenza vaccine (surface antigen, inactivated, virosome) (2053) Influenza vaccine (whole virion, inactivated) (0159) Influenza vaccine (whole virion, inactivated, prepared in cell cultures) (2308) Measles, mumps and rubella vaccine (live) (1057) Measles, mumps, rubella and varicella vaccine (live) (2442) Measles vaccine (live) (0213) Meningococcal group C conjugate vaccine (2112) Meningococcal polysaccharide vaccine (0250) Mumps vaccine (live) (0538) Pneumococcal polysaccharide conjugate vaccine (adsorbed) (2150) Pneumococcal polysaccharide vaccine (0966) Poliomyelitis vaccine (inactivated) (0214) Rabies vaccine for human use prepared in cell cultures (0216) Rubella vaccine (live) (0162) Shingles (herpes zoster) vaccine (live) (2418) Smallpox vaccine (live) (0164) Tick-borne encephalitis vaccine (inactivated) (1375) Typhoid polysaccharide vaccine (1160) Typhoid vaccine (0156) Varicella vaccine (live) (0648) Yellow fever vaccine (live) (0537) Herbal drugs and herbal drug preparations Akebia stem (2472) Bilberry fruit, dried (1588) Bilberry fruit, fresh (1602) Fenugreek (1323) Garlic powder (1216) Isatis root (2566) Milk thistle dry extract, refined and standardised (2071) White horehound (1835)
4 4 Pharmeuropa Useful information February 2018 Monographs Amikacin sulfate (1290) Amisulpride (1490) Ammonio methacrylate copolymer (type A) (2081) Ammonio methacrylate copolymer (type B) (2082) Aprotinin (0580) Aprotinin concentrated solution (0579) Arachis oil, hydrogenated (1171) Arachis oil, refined (0263) Benzylpenicillin (benzathine) tetrahydrate (0373) Botulinum toxin type A for injection (2113) Botulinum toxin type B for injection (2581) Calcifediol monohydrate (1295) Calcipotriol (2011) Calcipotriol monohydrate (2284) Calcium hydrogen phosphate (0981) Cellulose, microcrystalline (0316) Chlorobutanol (0382) Chlorobutanol hemihydrate (0383) Cholecalciferol concentrate (oily form) (0575) Cinchocaine hydrochloride (1088) Colistin sulfate (0320) Cystine (0998) Cytarabine (0760) Dihydrostreptomycin sulfate for veterinary use (0485) Dihydrotachysterol (2014) Disodium phosphate dodecahydrate (0118) Ebastine (2015) Erythropoietin concentrated solution (1316) Ethosuximide (0764) Glycerol (0496) Glycerol (85 per cent) (0497) Granisetron hydrochloride (1695) Griseofulvin (0182)
5 Pharmeuropa Useful information February Haemodialysis, solutions for (0128) Haemofiltration and haemodiafiltration, solutions for (0861) Hypromellose (0348) Kanamycin acid sulfate (0033) Kanamycin monosulfate (0032) Levocarnitine (1339) Lidocaine hydrochloride monohydrate (0227) Mepivacaine hydrochloride (1242) Methacrylic acid - ethyl acrylate copolymer (1:1) (1128) Methylcellulose (0345) Nystatin (0517) Pantoprazole sodium sesquihydrate (2296) Pentobarbital (0200) Pentobarbital sodium (0419) Peritoneal dialysis, solutions for (0862) Phenytoin (1253) Phenytoin sodium (0521) Potassium sulfate (1622) Primaquine diphosphate (0635) Protamine sulfate (0569) Rifamycin sodium (0432) Ropinirole hydrochloride (2604) Sodium sulfate, anhydrous (0099) Sodium sulfate decahydrate (0100) Starches, hydroxyethyl (1785) Streptokinase concentrated solution (0356) Streptomycin sulfate (0053) Tigecycline (2825) DELETED TEXTS The following texts will be deleted from the European Pharmacopoeia as of 1January GENERAL CHAPTERS Abnormal toxicity
6 6 Pharmeuropa Useful information February 2018 MONOGRAPHS Desoxycortone acetate (0322) Emetine hydrochloride pentahydrate (0081) Phytomenadione (1036)
Updated work programme of the European Pharmacopoeia
Pharmeuropa Useful information February 2017 1 Updated work programme of the European Pharmacopoeia (November 2016) The following items have been added to or deleted from the work programme during the
The Scientific Relevance of the ATT Today and from a historical Perspective
www.pei.de The Scientific Relevance of the ATT Today and from a historical Perspective Dr. Klaus Cussler EPAA International Workshop Towards global harmonization of 3Rs in biologicals 15-16 September 2015
List of texts adopted at the November 2014 session of the European Pharmacopoeia Commission
Pharmeuropa Useful information January 2015 1 List of texts adopted at the November 2014 session of the European Pharmacopoeia Commission NEW TEXTS Radiopharmaceutical preparations and starting materials
Annex 1. WHO Recommendations, Guidelines and other documents related to the manufacture and quality control of biological substances used in medicine
WHO related to the manufacture and quality control of biological substances used in medicine WHO are intended to provide guidance to those responsible for the production of biological substances as well
Updated work programme of the European Pharmacopoeia
Pharmeuropa Useful information March 2018 1 Updated work programme of the European Pharmacopoeia (November 2017) The following items have been added to or deleted from the work programme during the 159
Healthy People 2020 objectives were released in 2010, with a 10-year horizon to achieve the goals by 2020.
Appendix 1: Healthy People 2020 Immunization-related Objectives Healthy People provides science-based, 10-year national objectives for improving the health of all Americans. For three decades, Healthy
What are the new active vaccine recommendations in the Canadian Immunization Guide?
154 CCDR 17 April 2014 Volume 40-8 https://doi.org/10.14745/ccdr.v40i08a03 1 What are the new active vaccine recommendations in the Canadian Immunization Guide? Warshawsky B 1 and Gemmill I 2 on behalf
Family and Travel Vaccinations
Family and Travel Vaccinations We offer the full range of baby, child and family vaccinations. We are able to tailor schedules to your child s needs or international schedule. We have a suggested vaccination
CPT 2016 Code Changes
CPT 2016 Code Changes Code Changes - Medicine New CPT 2016 New Codes Code Description 69209 Removal impacted cerumen using irrigation/lavage, unilateral 90620 Meningococcal recombinant protein and outer
M I C R O B I O L O G Y
ninth edition TORTORA FUNKE CASE M I C R O B I O L O G Y a n i n t r o d u c t i o n 18 Practical Applications of Immunology PowerPoint Lecture Slide Presentation prepared by Christine L. Case Vaccine
CHAPTER ONE: EXECUTIVE SUMMARY. The Global Vaccine Industry CHAPTER TWO: INTRODUCTION TO VACCINES
CHAPTER ONE: EXECUTIVE SUMMARY The Global Vaccine Industry o Scope and Methodology o Overview o Pediatric Preventative Vaccines o The Market o Adult Preventative Vaccines o The Market o Total Market o
Adolescent vaccination strategies
Adolescent vaccination strategies Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases & Molecular Medicine University of Cape Town www.vacfa.uct.ac.za gregory.hussey@uct.ac.za
CyberScan Vaccine Stress Assessment
DEMO CyberScan Vaccine Stress Assessment % imbalance is calculated from 0-100%, with 100% corresponding to increased stress. Level correlates to the aspect of the body affected. Levels 1-3 correspond to
History of Vaccines. Stanley A. Plotkin ADVAC HISTORY /21/ :21 AM
History of Vaccines Stanley A. Plotkin ADVAC HISTORY 2014 5/21/2014 11:21 AM 1 Sources of Information on The History of Vaccines: Short: Medium: Long: Chapter 1 of the book Vaccines, By Plotkin and Plotkin
Immunizations for Children and Teens with Suppressed Immune Systems
Immunizations for Children and Teens with Suppressed Immune Systems Your child is starting treatment that will suppress the immune system. This will affect how your child s body responds to routine immunizations
Economics of Vaccine Development A Vaccine Manufacturer s Perspective
Economics of Vaccine Development A Vaccine Manufacturer s Perspective Gerald Voss The Value of Vaccines 2 29 diseases are currently preventable by vaccination Global public health Cervical cancer 1 Diphtheria
2016/17 Vaccination and Immunisation list of additional services and enhanced services
2016/17 Vaccination and Immunisation list of additional services and enhanced services 2016/17 Vaccination and Immunisation list of additional services and enhanced services Version number: 1 First published:
Armed Services Blood Program Immunization List
Immunization List NOTICE: The Department of Defense (DoD) assumes no risk for the use of this information by non-dod personnel, blood programs, or individual medical institutions. The use of this information
Stainless-steel vs Single-use: The Vaccines Perspective
Stainless-steel vs Single-use: The Vaccines Perspective CMO-Biomanufacturer Panel Tue 21 April, Noon-1:30pm, Exhibit Hall Daniel C.Vellom, PhD Sr. Director Global Technology Innovation 2015 INTERPHEX 1
Table Of Contents Executive Summary Introduction to Vaccines Pediatric Preventive Vaccines
Table Of Contents Executive Summary THE GLOBAL VACCINES INDUSTRY Scope and Methodology Overview Pediatric Preventative Vaccines THE MARKET Adult Preventative Vaccines THE MARKET TOTAL MARKET ISSUES AND
2017/18 Immunisation programmes list of additional and enhanced services
2017/18 Immunisation programmes list of additional and enhanced services 2017/18 Vaccination and Immunisation list of additional and enhanced services Version number: 1 First published: April 2017 Prepared
Appendix An Assessment Tool to Determine the Validity of Vaccine Doses
Appendix 4.4 - An Assessment Tool to Determine the Validity of Vaccine Doses Note: Refer to the Canadian Immunization Guide and New Brunswick (NB) immunization program directives for recommendations for
Coverage of Vaccines Medicaid and Child Health Plus Members
Coverage of Vaccines Medicaid and Child Health Plus Members For children between the ages 0-18, routine recommended vaccinations are covered through Vaccines for Children program [VFC]. Fidelis Care will
2018/19 Immunisation programmes list of additional and enhanced services
2018/19 Immunisation programmes list of additional and enhanced services 2018/19 Vaccination and Immunisation list of additional and enhanced services Version number: 1 First published: April 2018 Prepared
Vaccination-Strategies
Vaccination-Strategies Active immunity produced by vaccine Immunity and immunologic memory similar to natural infection but without risk of disease. General Rule: The more similar a vaccine is to the disease-causing
DEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report
DEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report July 2016 Report Description Reportable Events among all beneficiaries received from the Services over the past 5 years are used to create ranges
DEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report
DEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report May 2016 Report Description Reportable Events among all beneficiaries received from the Services over the past 5 years are used to create ranges
Aspirin. Iron Supplements
Interim Final Rules for Non-Grandfathered Group Health Plans and Health Insurance Issuers Coverage of Preventive Services Under the Patient Protection and Affordable Care Act Aspirin Aspirin to Prevent
Vaccinations for Adults
Case: Vaccinations for Adults Lisa Winston, MD University of California, San Francisco San Francisco General Hospital A 30-year old healthy woman comes for a routine visit. She is recently married and
Please read Chapters 5, 6 and 7 of your vaccine text for next Wednesday s lecture. Chapters 9, 17 and 8 for next Friday s lectures
Valerie Daggett Please read Chapters 5, 6 and 7 of your vaccine text for next Wednesday s lecture Chapters 9, 17 and 8 for next Friday s lectures ppt files for first 2 lectures Past exams Principles of
9/10/2018. Principles of Vaccination. Immunity. Antigen. September 2018
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Principles of Vaccination September 2018 Chapter 1 September 2018 Photographs and images included in
Vaccines and other immunological antimicrobial therapy 1
Vaccines and other immunological antimicrobial therapy 1 Vaccines Vaccine: a biological preparation that provides active acquired immunity to a particular disease. Vaccine typically contains an agent that
WHO International Biological Reference Preparations Held and distributed by the WHO International Laboratories for Biological Standards
WHO International Biological Preparations Anthrax spore vaccine. Lyophilized spore suspension of Bacillus anthracis strain 34 F2. 1 IU / ampoule. Anti-brucella abortus serum, bovine. Lyophilized. 1,000
VACCINATION. DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M.
VACCINATION DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M. IMMUNIZATION Immunization is defined as the procedure by which the body is prepared to fight against a specific disease. It is used to induce the
Guidelines for Vaccinating Pregnant Women
Guidelines for Vaccinating Pregnant Women March 2012 Guidelines for Vaccinating Pregnant Women Abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP) MARCH 2012 Risk
Role of Partnerships in Developing Innovative Vaccines: Brazil
Role of Partnerships in Developing Innovative Vaccines: Brazil SAGE Meeting, October 2010 Reinaldo Guimarães, M.D, MSc. Secretary of Science, Technology and Strategic Inputs Ministry of Health of Brazil
Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015
Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015 Dr. Susanne Keitel Director EDQM, Council of Europe Outline 1. The European Pharmacopoeia 2. The importance of
Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines
Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines 1 Vaccines: the single most effective medical intervention 2 Vaccines save lives Millions of cases
Recommended Health Screenings
Recommended Health Screenings UnitedHealthcare appreciates the preventive care you deliver to our members. Please use the below health screening chart to schedule screenings based on the member s age and
Cigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Routine Immunizations Table of Contents Coverage Policy... 1 General Background... 2 Coding/Billing Information... 3 References... 7 Effective Date... 4/15/2018
Benefit Interpretation
Benefit Interpretation Subject: Part B vs. Part D Vaccines Issue Number: BI-039 Applies to: Medicare Advantage Effective Date: May 1, 2017 Attachments: Part B Vaccines Diagnosis Code Limits Table of Contents
Guidelines for Vaccinating Pregnant Women
Guidelines for Vaccinating Pregnant Women April 2013 Guidelines for Vaccinating Pregnant Women Abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP) April 2013 Risk
BabyJabs Vaccines. All vaccines are mercury-free We use aluminium-free vaccines wherever possible
BabyJabs Vaccines All vaccines are mercury-free We use aluminium-free vaccines wherever possible BabyJabs is a dedicated children s immunisation service, offering a choice of single and small combination
14: Immunological products and vaccines
File name: Immunological Products and s Formulary BNF Original Date of issue: 30/10/2005 Last Reviewed: 23/11/2012 Version:4 Page 1 of 6 14: Immunological products and vaccines 14.1 Active immunity Live
Centers for Disease Control and Prevention. Final Revised Vaccine Information Materials for MMR
This document is scheduled to be published in the Federal Register on 03/15/2018 and available online at https://federalregister.gov/d/2018-05299, and on FDsys.gov BILLING CODE: 4163-18-P DEPARTMENT OF
Communicable Disease & Immunization
Communicable Disease & Immunization Ingham County Health Surveillance Book 2016 Communicable Disease & Immunization - 1 Communicable Disease & Immunization T he control of communicable disease and immunization,
Immunizations June 5, Brenda Ormesher, MD Infectious Disease Peacehealth Medical Group Springfield, OR
Immunizations June 5, 2015 Brenda Ormesher, MD Infectious Disease Peacehealth Medical Group Springfield, OR Disclosures None Goals Understand basic public health impact of immunization Recognize types
Procedure/Product Code Description
Proc. Type Code Procedure/Product Code Description ACA Primary Care Services Fees VFC 90585 TB $23.14 VFC 90632 Hep A $23.14 VFC 90633 Hep A $23.14 VFC 90634 Hep A $23.14 VFC 90636 Hep A - Hep B $23.14
Immunization in Cancer Patients:
Immunization in Cancer Patients: An Often Forgotten or Ignored Responsibility E.J. Bow MD, MSc., D. Bacteriol., FRCPC Infectious Diseases, Haematology/Oncology, Blood and Marrow Transplant Director, Infection
Modern Drug House.
+91-8048941768 Modern Drug House https://www.moderndrughouse.in/ We are one of the leading suppliers and traders of a wide range of Vaccine and Pharmaceutical Products. Owing to its effectiveness, purity
BabyJabs Vaccines. All vaccines are mercury-free We use aluminium-free vaccines wherever possible
BabyJabs Vaccines All vaccines are mercury-free We use aluminium-free vaccines wherever possible BabyJabs is a dedicated children s immunisation service, offering a choice of single and small combination
Public Statement: Medical Policy. Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many. Document: ARB0454:04.
ARBenefits Approval: 01/01/2012 Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many Medical Policy Title: Immunization Coverage Document: ARB0454:04 Administered by: Public Statement: 1.
Preventative Vaccines. Vaccines for Special Populations. Vaccinations for Adults: An Update. Vaccines Generally Available in the U.S.
Vaccinations for Adults: An Update Preventative Vaccines Need to be extremely safe Even greater issue as disease prevalence wanes or uncommon diseases targeted Lisa G. Winston, MD University of California,
Guidelines for immunisation of children following treatment with high dose chemotherapy and Haematopoietic Stem Cell Transplantation (HSCT)
Guidelines for immunisation of children following treatment with high dose chemotherapy and Haematopoietic Stem Cell Transplantation (HSCT) Version 2.0 Approved by Haem / Onc Senior Clinical Management
Medical Coverage Guidelines are subject to change as new information becomes available.
IMMUNIZATIONS Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage Guideline must
AKE WITH Y KEEP AND T
VACCINATION RECORD Vaccination, the best protection This booklet is an important document. It is the only record of all the vaccines you have received. You will need it all your life, so keep it in a safe
Young Adults (Ages 18 26)
Young Adults (Ages 18 26) Vaccines help prevent many diseases. Some new vaccines are available today that were not in use just a few years ago. By protecting yourself, you help protect everyone around
Patient reporting update
Patient reporting update François Houÿez Director of Treatment Information & Access, EURORDIS 8 th Pharmacovigilance stakeholders forum EMA, 15/06/2014 15/09/2014 eurordis.org 1 Spontaneous reporting in
2016 Vaccine Preventable Disease Summary
2016 Vaccine Preventable Disease Summary 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata Prepared October 2017 2016 Summary of Vaccine Preventable Diseases (VPDs) Reported to Ottawa County
Copyright regulations Warning
COMMONWEALTH OF AUSTRALIA Copyright regulations 1969 Warning This material has been reproduced and communicated to you by or on behalf of the University of Melbourne pursuant to part VB of the Copyright
Advisory Committee on Immunization Practices VACCINE ACRONYMS
Vaccine Acronyms Page 1 of 5 Advisy Committee on Immunization Practices VACCINE ACRONYMS Vaccines Included in the Immunization Schedules f Children, Adolescents, and Adults Following is a table of standardized
PREPARATION STANDARD MATERIAL HELD AT CODE WHO/BS DOCUMENT. 1st Reference Reagent, 2009
WHO International Biological Reference Preparations Held and Distributed by the WHO International Laboratories for Biological Standards Acellular pertussis vaccine for potency assay by modified mouse challenge
Vaccine Label Examples
Vaccine Label Examples With the large amount of vaccine carried in most clinics, staff can easily become confused about vaccines within the storage unit. Labeling the area where vaccines are stored can
Lichenase: a versatile, stable carrier molecule for vaccine and reagent development
Lichenase: a versatile, stable carrier molecule for vaccine and reagent development R. Mark Jones Center for Molecular Biotechnology, Fraunhofer USA New Cells, New Vaccines VII, From Protein to Product
Temperature Intelligence Solutions. Thermostability of Vaccines
Thermostability of Vaccines Why are all vaccines sensitive to heat and some to freezing? Why is thermostability of vaccine important? What can be done to improve the thermostability of vaccines? Goals
Vaccine. Specific defenses Immunity. natural. acquired. Live vaccines. Killed Inactivated vaccines. Cellular fraction vaccines
Introduction Vaccine has been a importance medical breakthrough in preventing morbidity and mortality from infectious diseases worldwide. Vaccination has managed to eradicate the deadly and mutilating
Approval / Acknowledgement Letter Ref No. / Diary no F.No.12-48/GSK/PAC- Synflorix/15-BD 25-Mar-15 2 GlaxoSmithKline Pharmaceuticals Limited.
1 GlaxoSmithKline Deletion of a n-significant in-process test limit during the purification process of the tetanus / diphtheria toxoids used in the manufacture of GSK's PCV vaccine [brand name: Synflorix]
Practical Applications of Immunology. Chapter 18
Practical Applications of Immunology Chapter 18 I. Vaccines A. Definition A suspension of organisms or fractions of organisms that is used to induce immunity (immunologic memory). The mechanism of memory
2015 Vaccine Preventable Disease Summary
2015 Vaccine Preventable Disease Summary 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata Prepared April 2016 2015 Summary of Vaccine Preventable Diseases (VPD) Reported to Ottawa County
CE Course Updates and Revisions 7/18/2015
CE Course Updates and Revisions 7/18/2015 This document contains updates and revisions made since January 2014. If you are using continuing education materials received before January and you are having
Routine Immunization Schedules. Section 2. Newfoundland and Labrador Immunization Manual. Routine Immunization Schedules
Newfoundland and Labrador Immunization Manual Section 2... 2.1 Routine and Delayed Immunization Schedules for Infants and Children... 2.2 Recommended Immunizations for Adults... 2.3 (Provinces and Territories)...
Vaccine Label Examples
Vaccine Label Examples With the large amount of vaccine carried in most clinics, staff can easily become confused about vaccines within the storage unit. Labeling the area where vaccines are stored can
ANNUAL HEALTH SCREENINGS AND IMMUNIZATIONS GUIDE MEN WOMEN ALL ADULTS CHILDREN
AND IMMUNIZATIONS GUIDE MEN WOMEN ALL ADULTS CHILDREN MEN PROSTATE CANCER Testicular exam Age 18+ PSA test Ages 50-75, based on risk WOMEN BREAST CANCER Self breast exam Monthly Clinical breast exam Annually
Preventive Care Services Summary
Preventive Care Services Summary Below is a list of preventive services along with the diagnoses and procedure codes that Community Health Options has determined to meet or exceed the requirements and
Preventive Care Services Summary
Preventive Care Services Summary Below is a list of preventive services along with the diagnoses and procedure codes that Community Health Options has determined to meet or exceed the requirements and
Immunization for Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients
Immunization for Adult Recipients January 4, 201 Immunization for Adult Hematopoietic Stem Cell Transplant () Recipients Revision Date: January 4, 201 Note: This guide is meant to supplement existing recommendations
VACCINE MANAGEMENT. Recommendations for Handling and Storage of Selected Biologicals. January 2001 DEPARTMENT OF HEALTH AND HUMAN SERVICES
VACCINE MANAGEMENT Recommendations for Handling and Storage of Selected Biologicals January 2001 DEPARTMENT OF HEALTH AND HUMAN SERVICES DTaP: Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis Vaccine
TRICARE Retail Vaccination Program Vaccine List - September 2018*
Diphtheria, tetanus and pertussis Diphtheria and tetanus toxoids adsorbed acellular pertussis adsorbed DT DTaP Diphtheria and tetanus toxoids adsorbed Daptacel, Infanrix Tetanus and diphtheria toxoids
BabyJabs Vaccines. All vaccines are mercury- free We use aluminium- free vaccines wherever possible
BabyJabs Vaccines All vaccines are mercury- free We use aluminium- free vaccines wherever possible BabyJabs is a dedicated children s immunisation service, offering a choice of single and small combination
Immunization Policy. Howard Heller, MD MPH MIT Medical
Immunization Policy Howard Heller, MD MPH MIT Medical 1 Vaccination vs. Immunization Vaccination: a vaccine is administered. Immunization: the response to the body from a vaccination. 2 Measles Mumps Rubella
Welcome to Wonersh Surgery. In order for us to provide you with the best medical care please complete this Questionnaire and pass to Reception.
PATIENT QUESTIONNAIRE WONERSH SURGERY Welcome to Wonersh Surgery. In order for us to provide you with the best medical care please complete this Questionnaire and pass to Reception. DETAILS ABOUT YOU:
7.0 Nunavut Childhood and Adult Immunization Schedules and Catch-up Aids
7.0 Nunavut Childhood and Adult Immunization Schedules and Catch-up Aids Contents Introduction Nunavut Recommended Childhood Immunization Schedule Nunavut Routine Adult Immunization Schedule Nunavut Immunization
Principles of Vaccination
Immunology and Vaccine-Preventable Diseases Immunology is a complicated subject, and a detailed discussion of it is beyond the scope of this text. However, an understanding of the basic function of the
Centers for Disease Control and Prevention. Proposed Revised Vaccine Information Materials for MMR
This document is scheduled to be published in the Federal Register on 10/18/2016 and available online at https://federalregister.gov/d/2016-25144, and on FDsys.gov BILLING CODE: 4163-18-P DEPARTMENT OF
Bharat Biotech. Hyderabad. Type of PAC (Supplement and Notifiable / Permission Granted by CDSCO) S. No Product
Bharat Biotech Hyderabad S. No Product Type of PAC (Supplement and / Permission Granted by CDSCO) PAC Details Date of NOC in manufacturing process of Oral Polio F.No. 12-63/BHARAT/(PACOPV)/13-BD 30.08.2013
Out-of-Network providers require prior authorization to render services to Neighborhood members.
IMMUNIZATIONS AND VACCINES BILLING AND REIMBURSEMENT POLICY This payment policy applies to all in-network providers who render services to Neighborhood Health Plan of Rhode Island (Neighborhood) subscribers
Child Health and Disability Prevention (CHDP) Program Code Conversion
Child Health and Disability Prevention (CHDP) Program Code Conversion Health s All s are effective for dates of service on or after July 1, 2017. (Select s for laboratory-only providers with effective
Preventive Care Services
Preventive Care Services Preventive Care Services What are preventive care services? It s important to visit your doctor regularly to get preventive care. Preventive care lets your doctor find potential
Up-to-date immunization coverage rates among 2-year olds in Saskatchewan First Nations communities
Up-to-date immunization coverage rates among 2-year olds in Saskatchewan First Nations communities Presented by: Michelle Allard-Johnson BScN, RN Regional Immunization Coordinator First Nations Inuit Health
UNIVERSITY OF UTAH INTERNATIONAL TRAVEL CLINIC Phone: Fax: N Medical Dr. Salt Lake City, UT 84132
Welcome to UNIVERSITY OF UTAH INTERNATIONAL TRAVEL CLINIC Phone: 801-801-581-2898 Fax: 801-585-7315 50 N Medical Dr. Salt Lake City, UT 84132 Our goal is to help you have a safe and enjoyable experience
Infectious Diseases Weekly Report. 12 January 2018 / Number 1. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 12 January / Number 1 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
PREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply.
An immunization that does not fall under one of the exclusions in the Certificate of Coverage is considered covered after the following conditions are satisfied: (1) FDA approval; (2) explicit ACIP recommendation
Immunization Requirements
Please Read Carefully. Health Care Provider: A physician (MD or DO), Nurse Practitioner, Physician s Assistant, or Registered Nurse. English: All immunization forms and laboratory reports must be submitted
Routine Immunization Schedules. Section 2. Newfoundland and Labrador Immunization Manual. Routine Immunization Schedules
Newfoundland and Labrador Immunization Manual Section 2 Routine Immunization Schedules Routine Immunization Schedules... 2.1-1 Policy on Routine Immunization Schedules... 2.1-2 Routine and Delayed Immunization
Immunizations are among the most cost effective and widely used public health interventions.
Focused Issue of This Month Recommended by the Korean Pediatric Society, 2008 Hoan Jong Lee, MD Department of Pediatrics, Seoul National University College of Medicine E mail : hoanlee@snu.ac.kr J Korean
Manitoba Health, Healthy Living and Seniors
Manitoba Health, Healthy Living and Seniors Manitoba Annual Immunization Surveillance Report, 2012 and 2013 January 1, 2012 to December 31, 2013 with 5-year average comparison (January 1, 2007 to December
Infectious Diseases Weekly Report. 23 August 2018 / Number 33. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 23 August / Number 33 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
Infectious Diseases Weekly Report. 8 November 2018 / Number 44. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 8 November / Number 44 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
Infectious Diseases Weekly Report. 15 November 2018 / Number 45. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 15 November / Number 45 Surveillance System in Tokyo, Japan The infectious diseases which all physicians